about
Need for a paradigm shift in therapeutic approaches to CNS injuryUpdate on Inflammatory Biomarkers and Treatments in Ischemic StrokeCardiolipin-mediated procoagulant activity of mitochondria contributes to traumatic brain injury-associated coagulopathy in miceThe immunology of stroke: from mechanisms to translationPost-stroke dementia - a comprehensive review.Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repairLeukocyte recruitment and ischemic brain injury.Autoimmune responses to brain following stroke.Activation of immune responses to brain antigens after stroke.Antigen-specific immune reactions to ischemic stroke.Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?CNS immune responses following experimental strokeThe Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review.Modulation of the postischemic immune response to improve stroke outcome.Long lasting local and systemic inflammation after cerebral hypoxic ischemia in newborn mice.Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes.Autoantibodies associated with prenatal and childhood exposure to environmental chemicals in Faroese childrenAutoimmune responses to the brain after stroke are associated with worse outcome.Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia.Myelin basic protein autoantibodies, white matter disease and stroke outcome.Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.Sensitization and tolerization to brain antigens in stroke.Immune and inflammatory responses to stroke: good or bad?Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion sizeInflammatory Disequilibrium in StrokeThe immunology of acute stroke.The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.Antigen Presentation After Stroke.Does B lymphocyte-mediated autoimmunity contribute to post-stroke dementia?Sensitization to brain antigens after stroke is augmented by lipopolysaccharide.Promiscuity of autoimmune responses to MBP after stroke.Strain-Related Differences in the Immune Response: Relevance to Human Stroke.Antibodies to myelin basic protein are associated with cognitive decline after stroke.Anti-basal ganglia antibodies in PANDAS.Brain-immune interactions in perinatal hypoxic-ischemic brain injury.Brain Ischemia Induces Diversified Neuroantigen-Specific T-Cell Responses That Exacerbate Brain Injury.Blocking Sympathetic Nervous System Reverses Partially Stroke-Induced Immunosuppression but does not Aggravate Functional Outcome After Experimental Stroke in Rats.
P2860
Q27025042-57532BC7-6510-4A33-8C15-647F386D2A56Q28078744-225F610E-B409-4F19-8FF4-1831DF4A5C68Q28395896-C093339D-C0A9-4D45-8EA5-5F44BC810566Q29620066-C2917DFD-7D9E-4CB9-A490-FB275B69FD80Q31155081-1C36F568-F917-436B-AF0B-5E6E1D2F8C01Q33583258-93EC417F-EB90-426B-A59F-AF15C3C54F9BQ33886526-9D5D1DE2-0D62-421D-B391-76D5909B24A9Q34049644-EEFA8F97-AC26-4C5B-B5B9-D60A13260C33Q34069139-A94508DF-BF27-4FFC-B531-909D6C0CC43DQ34171339-FF7CC062-F1D8-4858-9C62-4975733E53D1Q34219556-816A9570-34EA-45E0-AD34-D0EB43F5C7BBQ34232353-B8BBA242-D447-4FA9-A8BA-0977713C823FQ34237954-1FE968AF-3E55-47CF-97B6-C48F0B666FEFQ34238350-2BF7639B-21E9-44D2-836D-9C16A4513942Q34261803-7D5E548A-95CE-420E-A97E-1A8B4FC8586BQ34312538-44CB199D-05D1-4759-AA4D-2E085AC722CDQ35102612-19250D76-5663-43B2-926A-8EEBFBE4A5F0Q35243961-25E99D6A-385A-4EEB-9CEB-7BF13967F2C6Q35866882-814707F5-A7F3-4FD3-8338-744D98F9DA17Q36303569-842112C2-357B-4DB2-94FD-806D94ED9CE3Q37158146-CB8C405C-E2A3-41B8-9D7D-429727E4C2EEQ37244830-0B152063-5C8A-4F74-9A4C-FEE27E20FBE6Q37277232-C85008CC-E6F3-41C1-B629-D36BED5936C1Q37301326-22693317-D174-42D0-8BA9-835F66E1C91CQ37474699-F214E7DD-5D37-4A16-9E53-79BD41B3F467Q38016069-8491CD5C-3E74-4A2D-95C4-22F8AB6B6456Q38853641-63525C49-EBAF-4E80-B323-DD044831CA0CQ38925065-40D772C0-C0B7-44E5-8DD9-B56638CE375AQ38929223-64B45BF2-2B76-4711-B24B-C1EF80216A6DQ40384276-DFC5094F-D566-4EE9-A975-FD58D6384EB9Q40710496-2D5EDBB3-4665-4A0B-9AB2-4C486064B788Q42469075-BB1642E7-4E4A-497B-83E7-2847E2179A08Q42753452-2C45468C-316B-4630-AABE-96E4AAC47453Q44467641-0340DC48-9D12-412B-9DE7-5C11ACE594B1Q47624437-A881205B-2C7C-4361-BDD8-A7733B70C791Q52562980-F5E5222E-3C45-42D3-B455-146EB5BCFECDQ53127086-A0F6C5F8-AD31-4654-BFD4-2EEA0E2BAC93
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antibodies to brain antigens following stroke.
@ast
Antibodies to brain antigens following stroke.
@en
type
label
Antibodies to brain antigens following stroke.
@ast
Antibodies to brain antigens following stroke.
@en
prefLabel
Antibodies to brain antigens following stroke.
@ast
Antibodies to brain antigens following stroke.
@en
P2093
P356
P1433
P1476
Antibodies to brain antigens following stroke.
@en
P2093
Aronovich B
Bornstein NM
Michaelson DM
P304
P356
10.1212/WNL.56.4.529
P407
P577
2001-02-01T00:00:00Z